Accolade Financial Statements From 2010 to 2025
ACCD Stock | USD 7.00 0.02 0.29% |
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.3077 | Revenue |
Accolade Total Revenue |
|
Check Accolade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accolade's main balance sheet or income statement drivers, such as Tax Provision of 1.2 M, Net Interest Income of 7.2 M or Interest Income of 218 K, as well as many indicators such as Price To Sales Ratio of 1.89, Dividend Yield of 0.0 or PTB Ratio of 0.79. Accolade financial statements analysis is a perfect complement when working with Accolade Valuation or Volatility modules.
Accolade | Select Account or Indicator |
Accolade Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accolade Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accolade Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accolade Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Accolade Fundamental Market Drivers
Cash And Short Term Investments | 237 M |
Accolade Upcoming Events
25th of April 2024 Upcoming Quarterly Report | View | |
4th of July 2024 Next Financial Report | View | |
29th of February 2024 Next Fiscal Quarter End | View | |
25th of April 2024 Next Fiscal Year End | View | |
30th of November 2023 Last Quarter Report | View | |
28th of February 2023 Last Financial Announcement | View |
About Accolade Financial Statements
Accolade stakeholders use historical fundamental indicators, such as Accolade's revenue or net income, to determine how well the company is positioned to perform in the future. Although Accolade investors may analyze each financial statement separately, they are all interrelated. For example, changes in Accolade's assets and liabilities are reflected in the revenues and expenses on Accolade's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Accolade. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 40 M | 38.2 M | |
Total Revenue | 476.4 M | 245.5 M | |
Cost Of Revenue | 255.6 M | 137 M | |
Stock Based Compensation To Revenue | 0.13 | 0.10 | |
Sales General And Administrative To Revenue | 0.17 | 0.24 | |
Research And Ddevelopement To Revenue | 0.28 | 0.34 | |
Capex To Revenue | 0.03 | 0.04 | |
Revenue Per Share | 4.98 | 3.31 | |
Ebit Per Revenue | (0.25) | (0.26) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:Check out the analysis of Accolade Correlation against competitors. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share | Quarterly Revenue Growth 0.057 | Return On Assets | Return On Equity |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.